Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiol Therapeutics (CRDL) Other Working Capital Changes: 2021-2022

Historic Other Working Capital Changes for Cardiol Therapeutics (CRDL) over the last 2 years, with Sep 2022 value amounting to $1.1 million.

  • Cardiol Therapeutics' Other Working Capital Changes rose 127.07% to $1.1 million in Q3 2022 from the same period last year, while for Sep 2022 it was $3.1 million, marking a year-over-year change of. This contributed to the annual value of $156,987 for FY2024, which is 61.24% down from last year.
  • Per Cardiol Therapeutics' latest filing, its Other Working Capital Changes stood at $1.1 million for Q3 2022, which was up 117.96% from $504,616 recorded in Q2 2022.
  • In the past 5 years, Cardiol Therapeutics' Other Working Capital Changes ranged from a high of $2.0 million in Q4 2021 and a low of -$935,643 during Q1 2021.
  • Moreover, its 2-year median value for Other Working Capital Changes was $504,616 (2022), whereas its average is $635,724.
  • Within the past 5 years, the most significant YoY rise in Cardiol Therapeutics' Other Working Capital Changes was 127.07% (2022), while the steepest drop was 71.46% (2022).
  • Cardiol Therapeutics' Other Working Capital Changes (Quarterly) stood at $2.0 million in 2021, then skyrocketed by 127.07% to $1.1 million in 2022.
  • Its Other Working Capital Changes was $1.1 million in Q3 2022, compared to $504,616 in Q2 2022 and -$450,547 in Q1 2022.